Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-07

FDA Approved: FINGOLIMOD — Original Application (Solco Healthcare US, LLC)

View source ↗

Summary

The FDA approved the original application for fingolimod from Solco Healthcare US, LLC, enabling a generic fingolimod product for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fingolimod (fingolimod)

Snippet

ORIG AP for FINGOLIMOD (FINGOLIMOD)